NRx Pharmaceuticals, Inc. (NRXP)

NRx Pharmaceuticals Statistics

Total Valuation

NRXP has a market cap or net worth of $79.63 million. The enterprise value is $86.57 million.

Market Cap	79.63M
Enterprise Value	86.57M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

NRXP has 23.77 million shares outstanding. The number of shares has increased by 61.59% in one year.

Current Share Class	23.77M
Shares Outstanding	23.77M
Shares Change (YoY)	+61.59%
Shares Change (QoQ)	+9.29%
Owned by Insiders (%)	7.50%
Owned by Institutions (%)	5.86%
Float	16.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	20.51
PS Ratio	n/a
Forward PS	1.02
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.11

Current Ratio	0.11
Quick Ratio	0.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-174.88%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	39.68%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +117.53% in the last 52 weeks. The beta is 1.74, so NRXP's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	+117.53%
50-Day Moving Average	2.80
200-Day Moving Average	2.68
Relative Strength Index (RSI)	64.52
Average Volume (20 Days)	443,624

Short Selling Information

The latest short interest is 679,818, so 2.86% of the outstanding shares have been sold short.

Short Interest	679,818
Short Previous Month	632,714
Short % of Shares Out	2.86%
Short % of Float	4.14%
Short Ratio (days to cover)	1.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.13M
Pretax Income	-33.79M
Net Income	-33.79M
EBITDA	-14.13M
EBIT	-14.13M
Earnings Per Share (EPS)	-$2.35

Balance Sheet

The company has $2.91 million in cash and $9.85 million in debt, giving a net cash position of -$6.94 million or -$0.29 per share.

Cash & Cash Equivalents	2.91M
Total Debt	9.85M
Net Cash	-6.94M
Net Cash Per Share	-$0.29
Equity (Book Value)	-35.62M
Book Value Per Share	-1.83
Working Capital	-35.86M

Cash Flow

Operating Cash Flow	-11.91M
Capital Expenditures	n/a
Free Cash Flow	-11.91M
FCF Per Share	-$0.50

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-61.59%
Shareholder Yield	-61.59%
Earnings Yield	-42.44%
FCF Yield	-14.96%

Analyst Forecast

The average price target for NRXP is $31.40, which is 837.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$31.40
Price Target Difference	837.31%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 2, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Apr 2, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1